CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: teratogenic agent
Accession: CHEBI:50905
browse the term
Definition: A role played by a chemical compound in biological systems with adverse consequences in embryo developments, leading to birth defects, embryo death or altered development, growth retardation and functional defect.
Synonyms: related_synonym: agent teratogene; teratogen; teratogeno
G
ADCYAP1
adenylate cyclase activating polypeptide 1
multiple interactions
EXP
Nicotine inhibits the reaction [[Carbon Dioxide co-treated with Oxygen deficiency] results in decreased expression of ADCYAP1 protein]
CTD
PMID:28506824
NCBI chr 6:105,414,628...105,422,294
Ensembl chr 6:105,414,630...105,422,295
G
ADCYAP1R1
ADCYAP receptor type I
decreases expression
EXP
Nicotine results in decreased expression of ADCYAP1R1 protein
CTD
PMID:28506824
NCBI chr18:41,915,180...41,972,327
Ensembl chr18:41,917,402...41,972,301
G
AMH
anti-Mullerian hormone
decreases expression decreases secretion
EXP
Nicotine results in decreased expression of AMH mRNA Nicotine results in decreased secretion of AMH protein
CTD
PMID:32423882
NCBI chr 2:76,415,564...76,418,315
Ensembl chr 2:76,405,253...76,418,312
G
BCL2
BCL2 apoptosis regulator
decreases expression
EXP
Nicotine results in decreased expression of BCL2 mRNA
CTD
PMID:32423882
NCBI chr 1:158,337,403...158,518,214
Ensembl chr 1:158,288,544...158,518,879
G
CHRNA2
cholinergic receptor nicotinic alpha 2 subunit
multiple interactions
EXP
Nicotine affects the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] affects the expression of CHRNA2 protein]
CTD
PMID:28235547
NCBI chr14:11,193,732...11,204,334
Ensembl chr14:11,191,842...11,207,381
G
CHRNA3
cholinergic receptor nicotinic alpha 3 subunit
multiple interactions
EXP
Nicotine affects the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] affects the expression of CHRNA3 protein]
CTD
PMID:28235547
NCBI chr 7:47,361,710...47,382,743
Ensembl chr 7:47,361,778...47,384,303
G
CHRNA7
cholinergic receptor nicotinic alpha 7 subunit
multiple interactions
EXP
Nicotine affects the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] affects the expression of CHRNA7 protein]
CTD
PMID:28235547
NCBI chr 1:142,803,697...142,937,124
Ensembl chr 1:142,803,698...142,937,788
G
CHRNA9
cholinergic receptor nicotinic alpha 9 subunit
multiple interactions
EXP
Nicotine affects the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] affects the expression of CHRNA9 protein]
CTD
PMID:28235547
NCBI chr 8:31,430,933...31,456,385
Ensembl chr 8:31,443,043...31,456,384
G
CHRNB2
cholinergic receptor nicotinic beta 2 subunit
multiple interactions
EXP
Nicotine affects the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] affects the expression of CHRNB2 protein]
CTD
PMID:28235547
NCBI chr 4:95,196,992...95,211,084
Ensembl chr 4:95,198,717...95,211,037
G
CYP19A1
cytochrome P450 family 19 subfamily A member 1
decreases expression
EXP
Nicotine results in decreased expression of CYP19A1 mRNA
CTD
PMID:32423882
NCBI chr 1:120,596,235...120,627,806
Ensembl chr 1:120,367,667...120,695,899
G
FSHR
follicle stimulating hormone receptor
decreases expression
EXP
Nicotine results in decreased expression of FSHR mRNA
CTD
PMID:32423882
NCBI chr 3:91,607,236...91,775,255
Ensembl chr 3:91,607,305...91,774,683
G
INHBB
inhibin subunit beta B
decreases expression decreases secretion
EXP
Nicotine results in decreased expression of INHBB mRNA Nicotine results in decreased secretion of INHBB protein
CTD
PMID:32423882
NCBI chr15:30,999,994...31,004,405
Ensembl chr15:30,999,520...31,004,405
G
ITGB1
integrin subunit beta 1
decreases expression
EXP
Nicotine results in decreased expression of ITGB1 mRNA
CTD
PMID:32423882
NCBI chr10:56,078,393...56,130,608
Ensembl chr10:56,078,398...56,173,795
G
LAMB1
laminin subunit beta 1
decreases expression
EXP
Nicotine results in decreased expression of LAMB1 mRNA
CTD
PMID:32423882
NCBI chr 9:107,670,120...107,747,242
Ensembl chr 9:107,671,152...107,772,269
G
MAPK1
mitogen-activated protein kinase 1
decreases phosphorylation decreases expression
EXP
Nicotine results in decreased phosphorylation of MAPK1 protein Nicotine results in decreased expression of MAPK1 mRNA
CTD
PMID:32423882
NCBI chr14:50,083,079...50,165,528
Ensembl chr14:50,082,896...50,165,523
G
MAPK3
mitogen-activated protein kinase 3
decreases phosphorylation decreases expression
EXP
Nicotine results in decreased phosphorylation of MAPK3 protein Nicotine results in decreased expression of MAPK3 mRNA
CTD
PMID:32423882
NCBI chr 3:18,291,444...18,299,410
Ensembl chr 3:18,291,445...18,299,567
G
MAPK8
mitogen-activated protein kinase 8
decreases phosphorylation decreases expression
EXP
Nicotine results in decreased phosphorylation of MAPK8 protein Nicotine results in decreased expression of MAPK8 mRNA
CTD
PMID:32423882
NCBI chr14:88,988,914...89,108,875
Ensembl chr14:88,988,949...89,172,200
G
MMP9
matrix metallopeptidase 9
increases expression
EXP
Nicotine results in increased expression of MMP9 mRNA
CTD
PMID:32423882
NCBI chr17:48,179,690...48,186,782
Ensembl chr17:48,175,056...48,188,264
G
OCLN
occludin
decreases expression
EXP
Nicotine results in decreased expression of OCLN mRNA
CTD
PMID:32423882
NCBI chr16:47,600,175...47,652,435
Ensembl chr16:47,600,498...47,654,033
G
RPP38
ribonuclease P/MRP subunit p38
decreases expression
EXP
Nicotine results in decreased expression of RPP38 mRNA
CTD
PMID:32423882
NCBI chr10:46,720,135...46,725,962
Ensembl chr10:46,717,195...46,725,920
G
HSPA5
heat shock protein family A (Hsp70) member 5
multiple interactions
EXP
Aspirin inhibits the reaction [Hydrogen Peroxide results in increased expression of HSPA5 protein]
CTD
PMID:20665602
NCBI chr 1:265,930,044...265,934,959
Ensembl chr 1:265,930,045...265,934,904
G
PLA2G1B
phospholipase A2 group IB
multiple interactions
EXP
Aspirin promotes the reaction [PLA2G1B protein results in increased expression of PTGS2 mRNA]
CTD
PMID:10706128
NCBI chr14:40,314,520...40,322,315
Ensembl chr14:40,314,444...40,322,319
G
PTGS2
prostaglandin-endoperoxide synthase 2
multiple interactions
EXP
Aspirin promotes the reaction [PLA2G1B protein results in increased expression of PTGS2 mRNA]
CTD
PMID:10706128
NCBI chr 9:127,850,164...127,858,866
Ensembl chr 9:127,850,013...127,858,884
G
FABP4
fatty acid binding protein 4, adipocyte
decreases expression
EXP
4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid results in decreased expression of FABP4 mRNA
CTD
PMID:15583048
NCBI chr 4:55,096,400...55,101,209
Ensembl chr 4:55,096,404...55,101,897
G
GPD1
glycerol-3-phosphate dehydrogenase 1
decreases activity
EXP
4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid results in decreased activity of GPD1 protein
CTD
PMID:15583048
NCBI chr 5:16,008,179...16,021,676
Ensembl chr 5:16,007,448...16,017,825
G
NR2F1
nuclear receptor subfamily 2 group F member 1
increases expression
EXP
4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid results in increased expression of NR2F1 mRNA
CTD
PMID:15583048
NCBI chr 2:100,447,661...100,457,510
Ensembl chr 2:100,447,847...100,457,904
G
PPARG
peroxisome proliferator activated receptor gamma
decreases expression
EXP
4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid results in decreased expression of PPARG mRNA
CTD
PMID:15583048
NCBI chr13:68,301,566...68,433,951
Ensembl chr13:68,302,655...68,433,947
G
RXRA
retinoid X receptor alpha
decreases expression
EXP
4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid results in decreased expression of RXRA mRNA
CTD
PMID:15583048
NCBI chr 1:273,698,842...273,797,622
Ensembl chr 1:273,705,503...273,797,622
G
SREBP-1
sterol regulatory element binding protein 1
decreases expression
EXP
4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid results in decreased expression of SREBP-1 mRNA
CTD
PMID:15583048
G
KNG1
kininogen 1
increases activity
EXP
benazepril results in increased activity of KNG1 protein modified form
CTD
PMID:7890486
NCBI chr13:124,521,276...124,557,384
Ensembl chr13:124,521,277...124,557,376
G
ACO1
aconitase 1
increases expression
EXP
Clofibrate results in increased expression of ACO1 mRNA
CTD
PMID:17363680
NCBI chr10:33,937,833...34,001,895
Ensembl chr10:33,937,833...34,001,900
G
ACOX1
acyl-CoA oxidase 1
increases expression
EXP
Clofibrate results in increased expression of ACOX1 mRNA
CTD
PMID:16896063 PMID:17437637
NCBI chr12:5,450,913...5,479,550
Ensembl chr12:5,428,360...5,479,544
G
AGT
angiotensinogen
multiple interactions
EXP
Clofibrate inhibits the reaction [AGT protein modified form results in increased expression of EDN1 protein]
CTD
PMID:17105827
NCBI chr14:59,643,030...59,656,835
Ensembl chr14:59,643,292...59,672,428
G
ALB
albumin
decreases expression
EXP
Clofibrate results in decreased expression of ALB mRNA
CTD
PMID:16896063
NCBI chr 8:69,643,427...69,663,152
Ensembl chr 8:69,531,487...69,718,304
G
BAX
BCL2 associated X, apoptosis regulator
increases expression
EXP
Clofibrate results in increased expression of BAX mRNA
CTD
PMID:17437637
NCBI chr 6:54,222,341...54,228,150
Ensembl chr 6:54,187,260...54,228,144
G
BCL2L1
BCL2 like 1
decreases expression
EXP
Clofibrate results in decreased expression of BCL2L1 mRNA
CTD
PMID:17437637
NCBI chr17:35,366,139...35,415,798
Ensembl chr17:35,366,141...35,415,359
G
CAT
catalase
increases expression
EXP
Clofibrate results in increased expression of CAT mRNA
CTD
PMID:17437637
NCBI chr 2:26,493,664...26,533,881
Ensembl chr 2:26,487,653...26,581,452
G
CPT1A
carnitine palmitoyltransferase 1A
increases expression
EXP
Clofibrate results in increased expression of CPT1A mRNA
CTD
PMID:16896063 PMID:17363680
NCBI chr 2:4,250,642...4,293,914
Ensembl chr 2:4,233,099...4,293,984
G
CTSB
cathepsin B
increases expression
EXP
Clofibrate results in increased expression of CTSB mRNA
CTD
PMID:16896063
NCBI chr14:15,014,139...15,035,081
Ensembl chr14:15,011,711...15,034,737
G
DIO2
iodothyronine deiodinase 2
decreases expression
EXP
Clofibrate results in decreased expression of DIO2 mRNA
CTD
PMID:16896063
NCBI chr 7:103,096,414...103,110,749
Ensembl chr 7:103,096,425...103,323,258
G
EDN1
endothelin 1
decreases expression multiple interactions
EXP
Clofibrate results in decreased expression of EDN1 protein Clofibrate inhibits the reaction [AGT protein modified form results in increased expression of EDN1 protein]; Clofibrate inhibits the reaction [KNG1 protein modified form results in increased expression of EDN1 protein]; Clofibrate inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of EDN1 protein]; Nitric Oxide deficiency inhibits the reaction [Clofibrate results in decreased expression of EDN1 protein]
CTD
PMID:17105827
NCBI chr 7:8,752,018...8,758,354
Ensembl chr 7:8,751,695...8,758,348
G
FABP1
fatty acid binding protein 1
increases expression
EXP
Clofibrate results in increased expression of FABP1 mRNA
CTD
PMID:17363680
NCBI chr 3:57,850,511...57,854,966
Ensembl chr 3:57,850,499...57,854,964
G
GPX1
glutathione peroxidase 1
decreases expression
EXP
Clofibrate results in decreased expression of GPX1 mRNA
CTD
PMID:17437637
NCBI chr13:31,916,269...31,917,337
Ensembl chr13:31,914,932...31,917,335
G
JUN
Jun proto-oncogene, AP-1 transcription factor subunit
increases expression
EXP
Clofibrate results in increased expression of JUN mRNA
CTD
PMID:17437637
NCBI chr 6:153,686,425...153,687,635
G
KNG1
kininogen 1
multiple interactions
EXP
Clofibrate inhibits the reaction [KNG1 protein modified form results in increased expression of EDN1 protein]
CTD
PMID:17105827
NCBI chr13:124,521,276...124,557,384
Ensembl chr13:124,521,277...124,557,376
G
LOC110260333
hydroxymethylglutaryl-CoA synthase, mitochondrial-like
increases expression
EXP
Clofibrate results in increased expression of HMGCS2 mRNA
CTD
PMID:17363680
NCBI chr 4:101,385,486...101,404,273
Ensembl chr 4:101,385,512...101,443,405
G
MYC
MYC proto-oncogene, bHLH transcription factor
increases expression
EXP
Clofibrate results in increased expression of MYC mRNA
CTD
PMID:17437637
NCBI chr 4:12,455,141...12,460,360
Ensembl chr 4:12,455,119...12,461,078
G
NOS3
nitric oxide synthase 3
increases expression multiple interactions
EXP
Clofibrate results in increased expression of NOS3 protein calphostin C inhibits the reaction [Clofibrate results in increased expression of NOS3 protein]
CTD
PMID:17105827
NCBI chr18:6,209,218...6,228,912
Ensembl chr18:6,209,156...6,228,938
G
PPARA
peroxisome proliferator activated receptor alpha
increases expression multiple interactions
EXP
Clofibrate results in increased expression of PPARA; Clofibrate results in increased expression of PPARA protein calphostin C inhibits the reaction [Clofibrate results in increased expression of PPARA protein]; calphostin C inhibits the reaction [Clofibrate results in increased expression of PPARA]; Tetradecanoylphorbol Acetate inhibits the reaction [Clofibrate results in increased expression of PPARA]
CTD
PMID:17105827 PMID:20568414
NCBI chr 5:3,302,755...3,321,091
Ensembl chr 5:3,300,708...3,366,361
G
SCD
stearoyl-CoA desaturase
increases expression
EXP
Clofibrate results in increased expression of SCD mRNA
CTD
PMID:17363680
NCBI chr14:111,461,560...111,478,033
Ensembl chr14:111,461,560...111,478,031
G
SLC5A5
solute carrier family 5 member 5
increases expression
EXP
Clofibrate results in increased expression of SLC5A5 mRNA
CTD
PMID:16896063
NCBI chr 2:59,869,157...59,885,086
Ensembl chr 2:59,869,154...59,885,265
G
SOD1
superoxide dismutase 1
increases expression
EXP
Clofibrate results in increased expression of SOD1 mRNA
CTD
PMID:17437637
NCBI chr13:195,326,573...195,335,273
Ensembl chr13:195,326,649...195,337,749
G
THRA
thyroid hormone receptor alpha
decreases expression
EXP
Clofibrate results in decreased expression of THRA mRNA
CTD
PMID:16896063
NCBI chr12:22,270,506...22,296,684
Ensembl chr12:22,270,062...22,296,618
G
TNF
tumor necrosis factor
decreases expression
EXP
Clofibrate results in decreased expression of TNF mRNA
CTD
PMID:17437637
NCBI chr 7:23,699,635...23,702,393
Ensembl chr 7:23,699,636...23,703,655
G
TPO
thyroid peroxidase
increases expression
EXP
Clofibrate results in increased expression of TPO mRNA
CTD
PMID:16896063
NCBI chr 3:132,384,677...132,409,750
Ensembl chr 3:132,384,583...132,408,943
G
TSHR
thyroid stimulating hormone receptor
increases expression
EXP
Clofibrate results in increased expression of TSHR mRNA
CTD
PMID:16896063
NCBI chr 7:103,768,260...103,925,777
Ensembl chr 7:103,768,296...103,925,922
G
TTR
transthyretin
decreases expression
EXP
Clofibrate results in decreased expression of TTR mRNA
CTD
PMID:16896063
NCBI chr 6:115,496,338...115,503,974
Ensembl chr 6:115,496,193...115,503,977
G
PRDX2
peroxiredoxin 2
decreases activity
EXP
diethyl maleate results in decreased activity of PRDX2 protein
CTD
PMID:19208552
NCBI chr 2:66,207,829...66,211,474
Ensembl chr 2:66,207,796...66,213,567
G
ACADL
acyl-CoA dehydrogenase long chain
increases expression
EXP
Ethanol results in increased expression of ACADL mRNA
CTD
PMID:28069986
NCBI chr15:112,935,631...112,969,381
Ensembl chr15:112,933,498...112,969,578
G
ADAMTS8
ADAM metallopeptidase with thrombospondin type 1 motif 8
increases expression
EXP
Ethanol results in increased expression of ADAMTS8 mRNA
CTD
PMID:28069986
NCBI chr 9:57,090,313...57,113,077
Ensembl chr 9:57,090,615...57,110,476
G
AGPAT1
1-acylglycerol-3-phosphate O-acyltransferase 1
decreases expression
EXP
Ethanol results in decreased expression of AGPAT1 mRNA
CTD
PMID:28069986
NCBI chr 7:24,205,930...24,208,430
Ensembl chr 7:24,204,902...24,213,193
G
AGPS
alkylglycerone phosphate synthase
decreases expression
EXP
Ethanol results in decreased expression of AGPS mRNA
CTD
PMID:28069986
NCBI chr15:83,146,063...83,285,905
Ensembl chr15:83,145,573...83,391,970
G
ALDH9A1
aldehyde dehydrogenase 9 family member A1
increases expression
EXP
Ethanol results in increased expression of ALDH9A1 mRNA
CTD
PMID:28069986
NCBI chr 4:85,029,914...85,057,650
G
ALOX5
arachidonate 5-lipoxygenase
increases expression
EXP
Ethanol results in increased expression of ALOX5 mRNA
CTD
PMID:28069986
NCBI chr14:90,859,209...90,907,084
Ensembl chr14:90,858,975...90,907,094
G
APP
amyloid beta precursor protein
increases expression
EXP
Ethanol results in increased expression of APP mRNA
CTD
PMID:28069986
NCBI chr13:189,434,854...189,716,120
Ensembl chr13:189,434,869...189,716,057
G
ARSK
arylsulfatase family member K
increases expression
EXP
Ethanol results in increased expression of ARSK mRNA
CTD
PMID:28069986
NCBI chr 2:102,164,089...102,210,293
Ensembl chr 2:102,164,178...102,212,780
G
ATP6V0D2
ATPase H+ transporting V0 subunit d2
increases expression
EXP
Ethanol results in increased expression of ATP6V0D2 mRNA
CTD
PMID:28069986
NCBI chr 4:50,694,188...50,749,373
Ensembl chr 4:50,694,189...50,749,378
G
C5H12orf57
chromosome 5 C12orf57 homolog
increases expression
EXP
Ethanol results in increased expression of C12ORF57 mRNA
CTD
PMID:28069986
NCBI chr 5:63,779,510...63,781,307
Ensembl chr 5:63,779,511...63,781,308
G
CBS
cystathionine beta-synthase
multiple interactions
EXP
[Ethanol co-treated with Folic Acid deficiency] results in increased activity of CBS protein
CTD
PMID:16792574
NCBI chr13:206,205,942...206,231,363
G
CCNB1IP1
cyclin B1 interacting protein 1
decreases expression
EXP
Ethanol results in decreased expression of CCNB1IP1 mRNA
CTD
PMID:28069986
NCBI chr 7:78,553,680...78,576,057
Ensembl chr 7:78,553,764...78,575,516
G
CD109
CD109 molecule
increases expression
EXP
Ethanol results in increased expression of CD109 mRNA
CTD
PMID:28069986
NCBI chr 1:92,081,675...92,241,079
Ensembl chr 1:92,048,461...92,286,747
G
CD47
CD47 molecule
increases expression
EXP
Ethanol results in increased expression of CD47 mRNA
CTD
PMID:28069986
NCBI chr13:151,427,933...151,488,064
Ensembl chr13:151,429,288...151,502,164
G
CLDN4
claudin 4
decreases expression
EXP
Ethanol results in decreased expression of CLDN4 mRNA
CTD
PMID:28069986
NCBI chr 3:11,039,711...11,053,930
Ensembl chr 3:11,039,706...11,053,925
G
CLU
clusterin
increases expression
EXP
Ethanol results in increased expression of CLU mRNA
CTD
PMID:28069986
NCBI chr14:11,336,585...11,352,569
Ensembl chr14:11,336,590...11,352,475
G
CTH
cystathionine gamma-lyase
increases activity multiple interactions
EXP
Ethanol results in increased activity of CTH protein [Ethanol co-treated with Folic Acid deficiency] results in increased activity of CTH protein
CTD
PMID:16792574
NCBI chr 6:142,454,922...142,486,352
Ensembl chr 6:142,435,690...142,486,367
G
CYP51A1
cytochrome P450 family 51 subfamily A member 1
increases expression
EXP
Ethanol results in increased expression of CYP51 mRNA
CTD
PMID:28069986
NCBI chr 9:72,057,506...72,079,587
Ensembl chr 9:72,057,511...72,079,444
G
EEF2
eukaryotic translation elongation factor 2
decreases expression
EXP
Ethanol results in decreased expression of EEF2 mRNA
CTD
PMID:28069986
NCBI chr 2:74,746,541...74,756,687
Ensembl chr 2:74,747,080...74,756,680
G
EIF3L
eukaryotic translation initiation factor 3 subunit L
decreases expression
EXP
Ethanol results in decreased expression of EIF3L mRNA
CTD
PMID:28069986
NCBI chr 5:9,970,013...9,996,086
Ensembl chr 5:9,968,428...9,996,316
G
FBLN2
fibulin 2
increases expression
EXP
Ethanol results in increased expression of FBLN2 mRNA
CTD
PMID:28069986
NCBI chr13:70,757,255...70,830,430
Ensembl chr13:70,757,265...70,830,388
G
FKBP1A
FKBP prolyl isomerase 1A
decreases expression
EXP
Ethanol results in decreased expression of FKBP1A mRNA
CTD
PMID:28069986
NCBI chr17:33,910,047...33,935,212
G
FUCA1
alpha-L-fucosidase 1
increases expression
EXP
Ethanol results in increased expression of FUCA1 mRNA
CTD
PMID:28069986
NCBI chr 6:81,638,213...81,655,993
Ensembl chr 6:81,637,989...81,723,231
G
GABRB3
gamma-aminobutyric acid type A receptor subunit beta3
increases expression
EXP
Ethanol results in increased expression of GABRB3 mRNA
CTD
PMID:28069986
NCBI chr 1:140,566,443...140,906,516
Ensembl chr 1:140,566,287...140,905,658
G
GCLC
glutamate-cysteine ligase catalytic subunit
increases expression increases activity multiple interactions
EXP
Ethanol results in increased expression of GCLC mRNA Ethanol results in increased activity of GCLC protein [Ethanol co-treated with Folic Acid deficiency] results in increased activity of GCLC protein; [Ethanol co-treated with Folic Acid deficiency] results in increased expression of GCLC mRNA
CTD
PMID:16792574
NCBI chr 7:27,209,565...27,253,535
Ensembl chr 7:27,209,564...27,253,535
G
GPX6
glutathione peroxidase 6
increases expression
EXP
Ethanol results in increased expression of GPX6 mRNA
CTD
PMID:28069986
NCBI chr 7:22,256,013...22,267,992
Ensembl chr 7:22,256,038...22,267,992
G
GRTP1
growth hormone regulated TBC protein 1
decreases expression
EXP
Ethanol results in decreased expression of GRTP1 mRNA
CTD
PMID:28069986
NCBI chr11:78,618,720...78,637,502
Ensembl chr11:78,618,702...78,637,472
G
GSR
glutathione-disulfide reductase
increases activity increases expression multiple interactions
EXP
Ethanol results in increased activity of GSR protein Ethanol results in increased expression of GSR mRNA [Ethanol co-treated with Folic Acid deficiency] results in increased activity of GSR protein; [Ethanol co-treated with Folic Acid deficiency] results in increased expression of GSR mRNA
CTD
PMID:16792574
NCBI chr15:54,382,564...54,433,989
Ensembl chr15:54,382,567...54,433,989
G
GSS
glutathione synthetase
increases expression increases activity multiple interactions
EXP
Ethanol results in increased expression of GSS mRNA Ethanol results in increased activity of GSS protein [Ethanol co-treated with Folic Acid deficiency] results in increased activity of GSS protein; [Ethanol co-treated with Folic Acid deficiency] results in increased expression of GSS mRNA
CTD
PMID:16792574
NCBI chr17:38,316,199...38,342,253
Ensembl chr17:38,312,720...38,342,304
G
GSTA1
glutathione S-transferase alpha 1
increases expression multiple interactions
EXP
Ethanol results in increased expression of GSTA1 mRNA [Ethanol co-treated with Folic Acid deficiency] results in increased expression of GSTA1 mRNA
CTD
PMID:16792574
NCBI chr 7:46,538,743...46,550,781
Ensembl chr 7:46,538,032...46,567,728
G
HSD17B1
hydroxysteroid 17-beta dehydrogenase 1
increases expression
EXP
Ethanol results in increased expression of HSD17B1 mRNA
CTD
PMID:28069986
NCBI chr12:20,269,468...20,271,349
Ensembl chr12:20,269,056...20,279,569
G
HSD17B14
hydroxysteroid 17-beta dehydrogenase 14
decreases expression
EXP
Ethanol results in decreased expression of HSD17B14 mRNA
CTD
PMID:28069986
NCBI chr 6:54,125,229...54,144,143
G
HTRA1
HtrA serine peptidase 1
increases expression
EXP
Ethanol results in increased expression of HTRA1 mRNA
CTD
PMID:28069986
NCBI chr14:132,043,044...132,103,590
Ensembl chr14:132,043,006...132,103,595
G
ITIH5
inter-alpha-trypsin inhibitor heavy chain 5
increases expression
EXP
Ethanol results in increased expression of ITIH5 mRNA
CTD
PMID:28069986
NCBI chr10:63,688,416...63,764,566
Ensembl chr10:63,688,406...63,767,125
G
KIAA1217
KIAA1217
increases expression
EXP
Ethanol results in increased expression of KIAA1217 mRNA
CTD
PMID:28069986
NCBI chr10:50,706,713...51,032,010
Ensembl chr10:50,706,711...51,205,618
G
KRT6A
keratin 6A
increases expression
EXP
Ethanol results in increased expression of KRT6A mRNA
CTD
PMID:28069986
NCBI chr 5:17,830,147...17,851,113
Ensembl chr 5:17,780,928...17,868,402
G
LOC100513346
mitochondrial import inner membrane translocase subunit TIM16
decreases expression
EXP
Ethanol results in decreased expression of PAM16 mRNA
CTD
PMID:28069986
NCBI chr 3:37,928,098...38,005,619
Ensembl chr 3:37,989,180...38,005,617
G
MAP1S
microtubule associated protein 1S
decreases expression
EXP
Ethanol results in decreased expression of MAP1S mRNA
CTD
PMID:28069986
NCBI chr 2:60,003,116...60,043,133
Ensembl chr 2:59,999,162...60,029,939
G
MIOX
myo-inositol oxygenase
decreases expression
EXP
Ethanol results in decreased expression of MIOX mRNA
CTD
PMID:28069986
NCBI chr 5:249,312...251,547
G
MKNK2
MAPK interacting serine/threonine kinase 2
decreases expression
EXP
Ethanol results in decreased expression of MKNK2 mRNA
CTD
PMID:28069986
NCBI chr 2:76,510,302...76,522,885
Ensembl chr 2:76,510,303...76,522,885
G
NAALAD2
N-acetylated alpha-linked acidic dipeptidase 2
increases expression
EXP
Ethanol results in increased expression of NAALAD2 mRNA
CTD
PMID:28069986
NCBI chr 9:23,106,795...23,161,825
Ensembl chr 9:23,111,051...23,161,839
G
PLEKHO1
pleckstrin homology domain containing O1
increases expression
EXP
Ethanol results in increased expression of PLEKHO1 mRNA
CTD
PMID:28069986
NCBI chr 4:98,924,115...98,934,610
Ensembl chr 4:98,923,996...98,934,371
G
PRKD3
protein kinase D3
increases expression
EXP
Ethanol results in increased expression of PRKD3 mRNA
CTD
PMID:28069986
NCBI chr 3:102,840,666...102,949,128
Ensembl chr 3:102,842,229...102,944,085
G
PRNP
prion protein
increases expression
EXP
Ethanol results in increased expression of PRNP mRNA
CTD
PMID:28069986
NCBI chr17:13,694,195...13,705,126
Ensembl chr17:13,693,628...13,705,318
G
RPL13A
ribosomal protein L13a
decreases expression
EXP
Ethanol results in decreased expression of RPL13A mRNA
CTD
PMID:28069986
NCBI chr 6:54,551,772...54,568,752
G
SAFB
scaffold attachment factor B
increases expression
EXP
Ethanol results in increased expression of SAFB mRNA
CTD
PMID:28069986
NCBI chr 2:73,300,624...73,334,494
Ensembl chr 2:73,300,632...73,334,494
G
SLC7A4
solute carrier family 7 member 4
decreases expression
EXP
Ethanol results in decreased expression of SLC7A4 mRNA
CTD
PMID:28069986
NCBI chr14:50,631,693...50,638,381
Ensembl chr14:50,633,878...50,637,404
G
SOD1
superoxide dismutase 1
multiple interactions decreases activity
EXP
[Ethanol co-treated with Folic Acid deficiency] results in decreased activity of SOD1 protein Ethanol results in decreased activity of SOD1 protein
CTD
PMID:16792574
NCBI chr13:195,326,573...195,335,273
Ensembl chr13:195,326,649...195,337,749
G
SOD2
superoxide dismutase 2
multiple interactions increases activity
EXP
[Ethanol co-treated with Folic Acid deficiency] results in increased activity of SOD2 protein Ethanol results in increased activity of SOD2 protein
CTD
PMID:16792574
NCBI chr 1:7,679,352...7,689,564
Ensembl chr 1:7,651,280...7,691,723
G
SRGN
serglycin
increases expression
EXP
Ethanol results in increased expression of SRGN mRNA
CTD
PMID:28069986
NCBI chr14:72,183,368...72,199,262
Ensembl chr14:72,183,363...72,199,254
G
STXBP2
syntaxin binding protein 2
decreases expression
EXP
Ethanol results in decreased expression of STXBP2 mRNA
CTD
PMID:28069986
NCBI chr 2:71,504,575...71,513,446
Ensembl chr 2:71,504,569...71,513,422
G
TIMP2
TIMP metallopeptidase inhibitor 2
increases expression
EXP
Ethanol results in increased expression of TIMP2 mRNA
CTD
PMID:28069986
NCBI chr12:3,254,794...3,300,835
Ensembl chr12:3,254,493...3,300,835
G
TMEM98
transmembrane protein 98
increases expression
EXP
Ethanol results in increased expression of TMEM98 mRNA
CTD
PMID:28069986
NCBI chr12:42,087,691...42,101,152
Ensembl chr12:42,083,553...42,100,494
G
TNNI3
troponin I3, cardiac type
decreases expression
EXP
Ethanol results in decreased expression of TNNI3 mRNA
CTD
PMID:28069986
NCBI chr 6:59,366,828...59,377,490
Ensembl chr 6:59,366,828...59,382,728
G
TRAPPC5
trafficking protein particle complex 5
decreases expression
EXP
Ethanol results in decreased expression of TRAPPC5 mRNA
CTD
PMID:28069986
NCBI chr 2:71,470,441...71,472,614
Ensembl chr 2:71,470,445...71,472,549
G
TRPT1
tRNA phosphotransferase 1
decreases expression
EXP
Ethanol results in decreased expression of TRPT1 mRNA
CTD
PMID:28069986
NCBI chr 2:7,876,028...7,887,589
Ensembl chr 2:7,883,988...7,888,134
G
WFDC1
WAP four-disulfide core domain 1
increases expression
EXP
Ethanol results in increased expression of WFDC1 mRNA
CTD
PMID:28069986
NCBI chr 6:4,333,729...4,365,122
Ensembl chr 6:4,333,731...4,399,237
G
WNT5B
Wnt family member 5B
increases expression
EXP
Ethanol results in increased expression of WNT5B mRNA
CTD
PMID:28069986
NCBI chr 5:68,627,158...68,731,938
Ensembl chr 5:68,627,151...68,731,935
G
AKT2
AKT serine/threonine kinase 2
increases expression
EXP
Malathion results in increased expression of AKT2 mRNA
CTD
PMID:31535366
NCBI chr 6:48,555,785...48,620,472
Ensembl chr 6:48,555,789...48,587,919
G
BAX
BCL2 associated X, apoptosis regulator
increases expression
EXP
Malathion results in increased expression of BAX mRNA
CTD
PMID:31535366
NCBI chr 6:54,222,341...54,228,150
Ensembl chr 6:54,187,260...54,228,144
G
BCL2
BCL2 apoptosis regulator
decreases expression multiple interactions
EXP
Malathion results in decreased expression of BCL2 mRNA Melatonin inhibits the reaction [Malathion results in decreased expression of BCL2 mRNA]
CTD
PMID:31535366
NCBI chr 1:158,337,403...158,518,214
Ensembl chr 1:158,288,544...158,518,879
G
CAT
catalase
decreases expression multiple interactions
EXP
Malathion results in decreased expression of CAT mRNA Melatonin inhibits the reaction [Malathion results in decreased expression of CAT mRNA]
CTD
PMID:31535366
NCBI chr 2:26,493,664...26,533,881
Ensembl chr 2:26,487,653...26,581,452
G
CYP1A1
cytochrome P450 family 1 subfamily A member 1
decreases expression
EXP
Malathion results in decreased expression of CYP1A1 mRNA
CTD
PMID:31535366
NCBI chr 7:58,802,887...58,809,155
Ensembl chr 7:58,780,105...58,809,755
G
CYP1B1
cytochrome P450 family 1 subfamily B member 1
decreases expression
EXP
Malathion results in decreased expression of CYP1B1 mRNA
CTD
PMID:31535366
NCBI chr 3:102,195,743...102,205,687
Ensembl chr 3:102,195,741...102,206,750
G
DUOX2
dual oxidase 2
decreases expression
EXP
Malathion results in decreased expression of DUOX2 mRNA
CTD
PMID:31535366
NCBI chr 1:126,620,468...126,641,406
Ensembl chr 1:126,620,477...126,641,419
G
GPX4
glutathione peroxidase 4
increases expression
EXP
Malathion results in increased expression of GPX4 mRNA
CTD
PMID:31535366
NCBI chr 2:77,321,568...77,323,931
Ensembl chr 2:77,320,464...77,323,886
G
GPX6
glutathione peroxidase 6
increases expression
EXP
Malathion results in increased expression of GPX6 mRNA
CTD
PMID:31535366
NCBI chr 7:22,256,013...22,267,992
Ensembl chr 7:22,256,038...22,267,992
G
GSTA1
glutathione S-transferase alpha 1
decreases expression
EXP
Malathion results in decreased expression of GSTA1 mRNA
CTD
PMID:31535366
NCBI chr 7:46,538,743...46,550,781
Ensembl chr 7:46,538,032...46,567,728
G
MT-CO1
mitochondrially encoded cytochrome c oxidase I
affects expression
EXP
Malathion affects the expression of COX1 mRNA
CTD
PMID:17454254
NCBI chr MT:6,511...8,055
Ensembl chr MT:6,511...8,055
G
MT-CO3
mitochondrially encoded cytochrome c oxidase III
affects expression
EXP
Malathion affects the expression of COX3 mRNA
CTD
PMID:17454254
NCBI chr MT:9,800...10,583
Ensembl chr MT:9,800...10,583
G
PLIN2
perilipin 2
multiple interactions decreases expression
EXP
Melatonin inhibits the reaction [Malathion results in decreased expression of PLIN2 mRNA]; Melatonin inhibits the reaction [Malathion results in decreased expression of PLIN2 protein] Malathion results in decreased expression of PLIN2 mRNA; Malathion results in decreased expression of PLIN2 protein
CTD
PMID:31535366
NCBI chr 1:203,683,867...203,709,277
Ensembl chr 1:203,683,862...203,709,274
G
PPARG
peroxisome proliferator activated receptor gamma
multiple interactions decreases expression
EXP
Melatonin inhibits the reaction [Malathion results in decreased expression of PPARG mRNA]; Melatonin inhibits the reaction [Malathion results in decreased expression of PPARG protein] Malathion results in decreased expression of PPARG mRNA; Malathion results in decreased expression of PPARG protein
CTD
PMID:31535366
NCBI chr13:68,301,566...68,433,951
Ensembl chr13:68,302,655...68,433,947
G
SLC34A2
solute carrier family 34 member 2
increases expression
EXP
Malathion results in increased expression of SLC34A2 mRNA
CTD
PMID:31535366
NCBI chr 8:19,481,127...19,507,903
Ensembl chr 8:19,481,198...19,509,667
G
SOD2
superoxide dismutase 2
increases expression
EXP
Malathion results in increased expression of SOD2 mRNA
CTD
PMID:31535366
NCBI chr 1:7,679,352...7,689,564
Ensembl chr 1:7,651,280...7,691,723
G
SORD
sorbitol dehydrogenase
increases expression
EXP
Malathion results in increased expression of SORD mRNA
CTD
PMID:31535366
NCBI chr 1:126,659,198...126,701,084
Ensembl chr 1:126,655,135...126,700,858
G
TP53
tumor protein p53
increases expression multiple interactions
EXP
Malathion results in increased expression of TP53 mRNA Melatonin inhibits the reaction [Malathion results in increased expression of TP53 mRNA]
CTD
PMID:31535366
NCBI chr12:52,939,643...52,953,786
Ensembl chr12:52,939,643...52,953,819
G
ADCYAP1
adenylate cyclase activating polypeptide 1
multiple interactions
EXP
Nicotine inhibits the reaction [[Carbon Dioxide co-treated with Oxygen deficiency] results in decreased expression of ADCYAP1 protein]
CTD
PMID:28506824
NCBI chr 6:105,414,628...105,422,294
Ensembl chr 6:105,414,630...105,422,295
G
ADCYAP1R1
ADCYAP receptor type I
decreases expression
EXP
Nicotine results in decreased expression of ADCYAP1R1 protein
CTD
PMID:28506824
NCBI chr18:41,915,180...41,972,327
Ensembl chr18:41,917,402...41,972,301
G
AMH
anti-Mullerian hormone
decreases expression decreases secretion
EXP
Nicotine results in decreased expression of AMH mRNA Nicotine results in decreased secretion of AMH protein
CTD
PMID:32423882
NCBI chr 2:76,415,564...76,418,315
Ensembl chr 2:76,405,253...76,418,312
G
BCL2
BCL2 apoptosis regulator
decreases expression
EXP
Nicotine results in decreased expression of BCL2 mRNA
CTD
PMID:32423882
NCBI chr 1:158,337,403...158,518,214
Ensembl chr 1:158,288,544...158,518,879
G
CHRNA2
cholinergic receptor nicotinic alpha 2 subunit
multiple interactions
EXP
Nicotine affects the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] affects the expression of CHRNA2 protein]
CTD
PMID:28235547
NCBI chr14:11,193,732...11,204,334
Ensembl chr14:11,191,842...11,207,381
G
CHRNA3
cholinergic receptor nicotinic alpha 3 subunit
multiple interactions
EXP
Nicotine affects the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] affects the expression of CHRNA3 protein]
CTD
PMID:28235547
NCBI chr 7:47,361,710...47,382,743
Ensembl chr 7:47,361,778...47,384,303
G
CHRNA7
cholinergic receptor nicotinic alpha 7 subunit
multiple interactions
EXP
Nicotine affects the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] affects the expression of CHRNA7 protein]
CTD
PMID:28235547
NCBI chr 1:142,803,697...142,937,124
Ensembl chr 1:142,803,698...142,937,788
G
CHRNA9
cholinergic receptor nicotinic alpha 9 subunit
multiple interactions
EXP
Nicotine affects the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] affects the expression of CHRNA9 protein]
CTD
PMID:28235547
NCBI chr 8:31,430,933...31,456,385
Ensembl chr 8:31,443,043...31,456,384
G
CHRNB2
cholinergic receptor nicotinic beta 2 subunit
multiple interactions
EXP
Nicotine affects the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] affects the expression of CHRNB2 protein]
CTD
PMID:28235547
NCBI chr 4:95,196,992...95,211,084
Ensembl chr 4:95,198,717...95,211,037
G
CYP19A1
cytochrome P450 family 19 subfamily A member 1
decreases expression
EXP
Nicotine results in decreased expression of CYP19A1 mRNA
CTD
PMID:32423882
NCBI chr 1:120,596,235...120,627,806
Ensembl chr 1:120,367,667...120,695,899
G
FSHR
follicle stimulating hormone receptor
decreases expression
EXP
Nicotine results in decreased expression of FSHR mRNA
CTD
PMID:32423882
NCBI chr 3:91,607,236...91,775,255
Ensembl chr 3:91,607,305...91,774,683
G
INHBB
inhibin subunit beta B
decreases expression decreases secretion
EXP
Nicotine results in decreased expression of INHBB mRNA Nicotine results in decreased secretion of INHBB protein
CTD
PMID:32423882
NCBI chr15:30,999,994...31,004,405
Ensembl chr15:30,999,520...31,004,405
G
ITGB1
integrin subunit beta 1
decreases expression
EXP
Nicotine results in decreased expression of ITGB1 mRNA
CTD
PMID:32423882
NCBI chr10:56,078,393...56,130,608
Ensembl chr10:56,078,398...56,173,795
G
LAMB1
laminin subunit beta 1
decreases expression
EXP
Nicotine results in decreased expression of LAMB1 mRNA
CTD
PMID:32423882
NCBI chr 9:107,670,120...107,747,242
Ensembl chr 9:107,671,152...107,772,269
G
MAPK1
mitogen-activated protein kinase 1
decreases expression decreases phosphorylation
EXP
Nicotine results in decreased expression of MAPK1 mRNA Nicotine results in decreased phosphorylation of MAPK1 protein
CTD
PMID:32423882
NCBI chr14:50,083,079...50,165,528
Ensembl chr14:50,082,896...50,165,523
G
MAPK3
mitogen-activated protein kinase 3
decreases phosphorylation decreases expression
EXP
Nicotine results in decreased phosphorylation of MAPK3 protein Nicotine results in decreased expression of MAPK3 mRNA
CTD
PMID:32423882
NCBI chr 3:18,291,444...18,299,410
Ensembl chr 3:18,291,445...18,299,567
G
MAPK8
mitogen-activated protein kinase 8
decreases expression decreases phosphorylation
EXP
Nicotine results in decreased expression of MAPK8 mRNA Nicotine results in decreased phosphorylation of MAPK8 protein
CTD
PMID:32423882
NCBI chr14:88,988,914...89,108,875
Ensembl chr14:88,988,949...89,172,200
G
MMP9
matrix metallopeptidase 9
increases expression
EXP
Nicotine results in increased expression of MMP9 mRNA
CTD
PMID:32423882
NCBI chr17:48,179,690...48,186,782
Ensembl chr17:48,175,056...48,188,264
G
OCLN
occludin
decreases expression
EXP
Nicotine results in decreased expression of OCLN mRNA
CTD
PMID:32423882
NCBI chr16:47,600,175...47,652,435
Ensembl chr16:47,600,498...47,654,033
G
RPP38
ribonuclease P/MRP subunit p38
decreases expression
EXP
Nicotine results in decreased expression of RPP38 mRNA
CTD
PMID:32423882
NCBI chr10:46,720,135...46,725,962
Ensembl chr10:46,717,195...46,725,920
G
AKT1
AKT serine/threonine kinase 1
decreases phosphorylation
EXP
ochratoxin A results in decreased phosphorylation of AKT1 protein
CTD
PMID:30287338
G
ANXA5
annexin A5
decreases expression
EXP
ochratoxin A results in decreased expression of ANXA5 mRNA
CTD
PMID:14994279
NCBI chr 8:102,387,833...102,420,868
Ensembl chr 8:102,388,103...102,425,750
G
ATG5
autophagy related 5
multiple interactions increases expression
EXP
ATG5 protein affects the reaction [ochratoxin A results in increased cleavage of CASP3 protein]; ATG5 protein affects the reaction [ochratoxin A results in increased cleavage of PARP1 protein] ochratoxin A results in increased expression of ATG5 protein
CTD
PMID:28699257 PMID:30287338
NCBI chr 1:72,343,950...72,520,402
Ensembl chr 1:72,270,799...72,520,453
G
BCL2
BCL2 apoptosis regulator
decreases expression affects expression multiple interactions
EXP
ochratoxin A results in decreased expression of BCL2 mRNA ochratoxin A affects the expression of BCL2 mRNA TLR4 protein affects the reaction [ochratoxin A affects the expression of BCL2 mRNA]
CTD
PMID:28528741 PMID:29080797
NCBI chr 1:158,337,403...158,518,214
Ensembl chr 1:158,288,544...158,518,879
G
BECN1
beclin 1
multiple interactions increases expression
EXP
BECN1 protein affects the reaction [ochratoxin A results in increased cleavage of CASP3 protein]; BECN1 protein affects the reaction [ochratoxin A results in increased cleavage of PARP1 protein] ochratoxin A results in increased expression of BECN1 protein
CTD
PMID:30287338
NCBI chr12:20,041,914...20,054,249
Ensembl chr12:20,041,956...20,054,373
G
BRCA1
BRCA1 DNA repair associated
increases expression
EXP
ochratoxin A results in increased expression of BRCA1 protein
CTD
PMID:32454083
NCBI chr12:19,788,087...19,854,515
Ensembl chr12:19,786,020...19,855,570
G
CASP3
caspase 3
multiple interactions increases cleavage
EXP
3-methyladenine promotes the reaction [ochratoxin A results in increased cleavage of CASP3 protein]; ATG5 protein affects the reaction [ochratoxin A results in increased cleavage of CASP3 protein]; BECN1 protein affects the reaction [ochratoxin A results in increased cleavage of CASP3 protein]; Chloroquine promotes the reaction [ochratoxin A results in increased cleavage of CASP3 protein]
CTD
PMID:30287338
NCBI chr15:45,744,320...45,753,252
Ensembl chr15:45,742,749...45,763,773
G
CAT
catalase
decreases expression
EXP
ochratoxin A results in decreased expression of CAT protein
CTD
PMID:18547704
NCBI chr 2:26,493,664...26,533,881
Ensembl chr 2:26,487,653...26,581,452
G
CRYAB
crystallin alpha B
increases expression
EXP
ochratoxin A results in increased expression of CRYAB mRNA
CTD
PMID:14994279
NCBI chr 9:39,638,505...39,643,530
Ensembl chr 9:39,638,502...39,643,530
G
CYP2G2
cytochrome P450 family 2 subfamily G member 2
decreases expression
EXP
ochratoxin A results in decreased expression of CYP2A6 mRNA
CTD
PMID:14994279
NCBI chr 6:49,069,613...49,084,953
G
DAD1
defender against cell death 1
decreases expression
EXP
ochratoxin A results in decreased expression of DAD1 mRNA
CTD
PMID:14994279
NCBI chr 7:76,432,040...76,457,403
Ensembl chr 7:76,432,029...76,457,192
G
DNMT1
DNA methyltransferase 1
increases expression multiple interactions
EXP
ochratoxin A results in increased expression of DNMT1 mRNA; ochratoxin A results in increased expression of DNMT1 protein Decitabine inhibits the reaction [ochratoxin A results in increased expression of DNMT1 mRNA]; Decitabine inhibits the reaction [ochratoxin A results in increased expression of DNMT1 protein]
CTD
PMID:29080797 PMID:30923867
NCBI chr 2:68,981,564...69,040,364
Ensembl chr 2:68,981,564...69,029,919
G
DNMT3A
DNA methyltransferase 3 alpha
increases expression
EXP
ochratoxin A results in increased expression of DNMT3A mRNA
CTD
PMID:29080797 PMID:30923867
NCBI chr 3:113,501,972...113,609,148
Ensembl chr 3:113,528,926...113,609,139
G
GCLC
glutamate-cysteine ligase catalytic subunit
decreases expression multiple interactions
EXP
ochratoxin A results in decreased expression of GCLC mRNA ochratoxin A inhibits the reaction [sulforafan results in increased expression of GCLC mRNA]
CTD
PMID:18547363
NCBI chr 7:27,209,565...27,253,535
Ensembl chr 7:27,209,564...27,253,535
G
GLMN
glomulin, FKBP associated protein
increases expression
EXP
ochratoxin A results in increased expression of GLMN mRNA
CTD
PMID:14994279
NCBI chr 4:124,773,957...124,813,336
Ensembl chr 4:124,773,979...124,813,337
G
GSTA1
glutathione S-transferase alpha 1
multiple interactions decreases expression
EXP
ochratoxin A inhibits the reaction [sulforafan results in increased expression of GSTA1 mRNA] ochratoxin A results in decreased expression of GSTA1 mRNA
CTD
PMID:18547363
NCBI chr 7:46,538,743...46,550,781
Ensembl chr 7:46,538,032...46,567,728
G
HDAC1
histone deacetylase 1
multiple interactions increases expression
EXP
Panobinostat inhibits the reaction [ochratoxin A results in increased expression of HDAC1 mRNA]; Panobinostat inhibits the reaction [ochratoxin A results in increased expression of HDAC1 protein] ochratoxin A results in increased expression of HDAC1 mRNA; ochratoxin A results in increased expression of HDAC1 protein
CTD
PMID:29080797
NCBI chr 6:88,749,611...88,785,220
Ensembl chr 6:88,749,634...88,785,412
G
HSP90B1
heat shock protein 90 beta family member 1
increases expression decreases expression
EXP
ochratoxin A results in increased expression of HSP90B1 mRNA ochratoxin A results in decreased expression of HSP90B1 mRNA
CTD
PMID:14994279
NCBI chr 5:80,511,513...80,531,016
Ensembl chr 5:80,511,507...80,531,005
G
HSPA5
heat shock protein family A (Hsp70) member 5
increases expression
EXP
ochratoxin A results in increased expression of HSPA5 mRNA; ochratoxin A results in increased expression of HSPA5 protein
CTD
PMID:28699257
NCBI chr 1:265,930,044...265,934,959
Ensembl chr 1:265,930,045...265,934,904
G
HSPD1
heat shock protein family D (Hsp60) member 1
decreases expression
EXP
ochratoxin A results in decreased expression of HSPD1 mRNA
CTD
PMID:14994279
NCBI chr15:101,360,355...101,373,498
Ensembl chr15:101,360,094...101,373,527
G
ID2
inhibitor of DNA binding 2
decreases expression
EXP
ochratoxin A results in decreased expression of ID2 mRNA
CTD
PMID:14994279
NCBI chr 3:127,500,759...127,503,207
Ensembl chr 3:127,500,759...127,503,257
G
IGFBP2
insulin like growth factor binding protein 2
increases expression
EXP
ochratoxin A results in increased expression of IGFBP2 mRNA
CTD
PMID:14994279
NCBI chr15:118,822,092...118,850,985
Ensembl chr15:118,822,047...118,850,976
G
IL1A
interleukin 1 alpha
multiple interactions
EXP
ochratoxin A promotes the reaction [Lipopolysaccharides results in increased expression of IL1A mRNA]; TLR4 protein affects the reaction [ochratoxin A promotes the reaction [Lipopolysaccharides results in increased expression of IL1A mRNA]]
CTD
PMID:28528741
NCBI chr 3:43,718,320...43,731,668
Ensembl chr 3:43,718,368...43,731,119
G
IL2
interleukin 2
decreases secretion
EXP
ochratoxin A results in decreased secretion of IL2 protein
CTD
PMID:28699257
NCBI chr 8:101,640,938...101,645,683
Ensembl chr 8:101,640,944...101,645,609
G
IL4
interleukin 4
increases expression
EXP
ochratoxin A results in increased expression of IL4 mRNA
CTD
PMID:14994279
NCBI chr 2:134,986,817...134,994,365
Ensembl chr 2:134,986,817...134,994,365
G
IL6
interleukin 6
increases expression multiple interactions
EXP
ochratoxin A results in increased expression of IL6 mRNA NFE2L2 protein affects the reaction [ochratoxin A results in increased expression of IL6 mRNA]
CTD
PMID:28710020
NCBI chr 9:91,506,421...91,510,830
Ensembl chr 9:91,506,340...91,511,263
G
JAK2
Janus kinase 2
multiple interactions increases phosphorylation
EXP
Decitabine inhibits the reaction [ochratoxin A results in increased phosphorylation of JAK2 protein]
CTD
PMID:30923867
NCBI chr 1:216,849,744...217,002,310
Ensembl chr 1:216,848,686...217,002,148
G
LOC100522201
histone H2AX
multiple interactions increases expression
EXP
alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [ochratoxin A results in increased expression of H2AX protein]; Decitabine inhibits the reaction [ochratoxin A results in increased expression of H2AX protein]; STAT3 protein affects the reaction [ochratoxin A results in increased expression of H2AX protein]
CTD
PMID:30923867
NCBI chr 9:46,308,824...46,310,494
Ensembl chr 9:46,309,653...46,310,084
G
MAPK1
mitogen-activated protein kinase 1
increases phosphorylation multiple interactions
EXP
ochratoxin A results in increased phosphorylation of MAPK1 protein ochratoxin A inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]
CTD
PMID:28528741 PMID:28699257
NCBI chr14:50,083,079...50,165,528
Ensembl chr14:50,082,896...50,165,523
G
MAPK3
mitogen-activated protein kinase 3
multiple interactions increases phosphorylation
EXP
ochratoxin A inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK3 protein] ochratoxin A results in increased phosphorylation of MAPK3 protein
CTD
PMID:28528741 PMID:28699257
NCBI chr 3:18,291,444...18,299,410
Ensembl chr 3:18,291,445...18,299,567
G
MTOR
mechanistic target of rapamycin kinase
decreases phosphorylation
EXP
ochratoxin A results in decreased phosphorylation of MTOR protein
CTD
PMID:30287338
NCBI chr 6:71,286,989...71,412,913
Ensembl chr 6:71,286,989...71,412,888
G
MYD88
MYD88 innate immune signal transduction adaptor
multiple interactions
EXP
ochratoxin A promotes the reaction [Lipopolysaccharides results in increased expression of MYD88 mRNA]; ochratoxin A promotes the reaction [Lipopolysaccharides results in increased expression of MYD88 protein]
CTD
PMID:28528741
NCBI chr13:22,976,951...22,979,568
Ensembl chr13:22,964,071...22,983,109
G
NEIL1
nei like DNA glycosylase 1
decreases expression multiple interactions
EXP
ochratoxin A results in decreased expression of NEIL1 mRNA alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [ochratoxin A results in decreased expression of NEIL1 mRNA]; Decitabine inhibits the reaction [ochratoxin A results in decreased expression of NEIL1 mRNA]; STAT3 protein affects the reaction [ochratoxin A results in decreased expression of NEIL1 mRNA]
CTD
PMID:30923867
NCBI chr 7:58,261,761...58,269,001
Ensembl chr 7:58,261,761...58,283,092
G
NEIL3
nei like DNA glycosylase 3
multiple interactions decreases expression
EXP
alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [ochratoxin A results in decreased expression of NEIL3 mRNA]; Decitabine inhibits the reaction [ochratoxin A results in decreased expression of NEIL3 mRNA]; STAT3 protein affects the reaction [ochratoxin A results in decreased expression of NEIL3 mRNA]
CTD
PMID:30923867
NCBI chr15:39,416,073...39,632,313
Ensembl chr15:39,581,856...39,632,310
G
NFE2L2
nuclear factor, erythroid 2 like 2
decreases activity multiple interactions decreases expression
EXP
ochratoxin A results in decreased activity of NFE2L2 protein NFE2L2 protein affects the reaction [ochratoxin A results in increased expression of IL6 mRNA]; NFE2L2 protein affects the reaction [ochratoxin A results in increased expression of TGFB1 mRNA]; NFE2L2 protein affects the reaction [ochratoxin A results in increased expression of TP53 protein]; ochratoxin A inhibits the reaction [sulforafan affects the localization of NFE2L2 protein]; ochratoxin A inhibits the reaction [sulforafan results in increased activity of NFE2L2 protein]; ochratoxin A inhibits the reaction [sulforafan results in increased expression of NFE2L2 mRNA] ochratoxin A results in decreased expression of NFE2L2 mRNA
CTD
PMID:18547363 PMID:18547704 PMID:28710020
NCBI chr15:82,967,485...83,146,185
Ensembl chr15:82,973,648...83,146,183
G
NPM1
nucleophosmin 1
increases expression
EXP
ochratoxin A results in increased expression of NPM1 mRNA
CTD
PMID:14994279
NCBI chr16:52,767,263...52,781,862
Ensembl chr16:52,765,296...52,781,740
G
OGG1
8-oxoguanine DNA glycosylase
decreases expression multiple interactions
EXP
ochratoxin A results in decreased expression of OGG1 mRNA alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [ochratoxin A results in decreased expression of OGG1 mRNA]; Decitabine inhibits the reaction [ochratoxin A results in decreased expression of OGG1 mRNA]; STAT3 protein affects the reaction [ochratoxin A results in decreased expression of OGG1 mRNA]
CTD
PMID:30923867
NCBI chr13:66,038,669...66,045,478
G
PARP1
poly(ADP-ribose) polymerase 1
increases cleavage increases expression multiple interactions
EXP
ochratoxin A results in increased cleavage of PARP1 protein ochratoxin A results in increased expression of PARP1 protein 3-methyladenine promotes the reaction [ochratoxin A results in increased cleavage of PARP1 protein]; ATG5 protein affects the reaction [ochratoxin A results in increased cleavage of PARP1 protein]; BECN1 protein affects the reaction [ochratoxin A results in increased cleavage of PARP1 protein]; Chloroquine promotes the reaction [ochratoxin A results in increased cleavage of PARP1 protein]
CTD
PMID:30287338 PMID:32454083
NCBI chr10:14,203,157...14,241,164
Ensembl chr10:14,203,159...14,241,197
G
PCK1
phosphoenolpyruvate carboxykinase 1
decreases expression
EXP
ochratoxin A results in decreased expression of PCK1 mRNA; ochratoxin A results in decreased expression of PCK1 protein
CTD
PMID:3753873
NCBI chr17:57,930,507...57,936,523
Ensembl chr17:57,930,432...57,938,896
G
PCNA
proliferating cell nuclear antigen
decreases expression
EXP
ochratoxin A results in decreased expression of PCNA protein
CTD
PMID:32454083
NCBI chr17:14,137,746...14,142,584
Ensembl chr17:14,125,814...14,185,276
G
PFDN5
prefoldin subunit 5
decreases expression
EXP
ochratoxin A results in decreased expression of PFDN5 mRNA
CTD
PMID:14994279
NCBI chr 5:18,512,637...18,516,928
Ensembl chr 5:18,512,719...18,525,877
G
PPIA
peptidylprolyl isomerase A
increases expression
EXP
ochratoxin A results in increased expression of PPIA mRNA
CTD
PMID:14994279
NCBI chr18:50,563,130...50,566,857
G
PRDX1
peroxiredoxin 1
decreases expression
EXP
ochratoxin A results in decreased expression of PRDX1 mRNA
CTD
PMID:14994279
NCBI chr 6:165,847,390...165,859,918
Ensembl chr 6:165,824,520...165,861,442
G
PTMA
prothymosin alpha
decreases expression
EXP
ochratoxin A results in decreased expression of PTMA mRNA
CTD
PMID:14994279
NCBI chr15:132,353,763...132,361,442
Ensembl chr15:132,355,655...132,361,435
G
RAD51
RAD51 recombinase
increases expression
EXP
ochratoxin A results in increased expression of RAD51 protein
CTD
PMID:32454083
NCBI chr 1:130,592,414...130,640,326
Ensembl chr 1:130,586,647...130,640,136
G
RELA
RELA proto-oncogene, NF-kB subunit
multiple interactions
EXP
ochratoxin A inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of RELA protein]
CTD
PMID:28528741
NCBI chr 2:6,594,869...6,602,684
Ensembl chr 2:6,593,969...6,603,471
G
RPA2
replication protein A2
increases expression
EXP
ochratoxin A results in increased expression of RPA2 protein
CTD
PMID:32454083
NCBI chr 6:85,032,604...85,045,899
Ensembl chr 6:85,031,578...85,045,916
G
RPS5
ribosomal protein S5
increases expression
EXP
ochratoxin A results in increased expression of RPS5 mRNA
CTD
PMID:14994279
NCBI chr 6:62,967,955...62,974,353
Ensembl chr 6:62,921,635...62,974,354
G
SOCS3
suppressor of cytokine signaling 3
increases expression multiple interactions
EXP
ochratoxin A results in increased expression of SOCS3 mRNA; ochratoxin A results in increased expression of SOCS3 protein Decitabine promotes the reaction [ochratoxin A results in increased expression of SOCS3 mRNA]; Decitabine promotes the reaction [ochratoxin A results in increased expression of SOCS3 protein]
CTD
PMID:30923867
NCBI chr12:3,643,832...3,647,015
Ensembl chr12:3,643,929...3,647,012
G
SOD1
superoxide dismutase 1
decreases activity
EXP
ochratoxin A results in decreased activity of SOD1 protein
CTD
PMID:18547704
NCBI chr13:195,326,573...195,335,273
Ensembl chr13:195,326,649...195,337,749
G
SQSTM1
sequestosome 1
multiple interactions decreases expression
EXP
Chloroquine inhibits the reaction [ochratoxin A results in decreased expression of SQSTM1 protein]
CTD
PMID:30287338
NCBI chr 2:78,752,768...78,763,998
Ensembl chr 2:78,752,768...78,784,256
G
STAT3
signal transducer and activator of transcription 3
multiple interactions increases phosphorylation
EXP
Decitabine inhibits the reaction [ochratoxin A results in increased phosphorylation of STAT3 protein]; STAT3 protein affects the reaction [ochratoxin A results in decreased expression of NEIL1 mRNA]; STAT3 protein affects the reaction [ochratoxin A results in decreased expression of NEIL3 mRNA]; STAT3 protein affects the reaction [ochratoxin A results in decreased expression of OGG1 mRNA]; STAT3 protein affects the reaction [ochratoxin A results in increased expression of H2AX protein]
CTD
PMID:30923867
NCBI chr12:20,407,316...20,471,091
Ensembl chr12:20,407,233...20,472,993
G
SUMO1
small ubiquitin like modifier 1
decreases expression
EXP
ochratoxin A results in decreased expression of SUMO1 mRNA
CTD
PMID:14994279
NCBI chr15:105,820,237...105,850,099
Ensembl chr15:105,815,281...105,850,943
G
TGFB1
transforming growth factor beta 1
increases expression multiple interactions
EXP
ochratoxin A results in increased expression of TGFB1 mRNA NFE2L2 protein affects the reaction [ochratoxin A results in increased expression of TGFB1 mRNA]; sulforafan inhibits the reaction [ochratoxin A results in increased expression of TGFB1 mRNA]
CTD
PMID:28710020
NCBI chr 6:49,332,169...49,348,642
Ensembl chr 6:49,332,169...49,349,048
G
TIMP2
TIMP metallopeptidase inhibitor 2
increases expression
EXP
ochratoxin A results in increased expression of TIMP2 mRNA
CTD
PMID:14994279
NCBI chr12:3,254,794...3,300,835
Ensembl chr12:3,254,493...3,300,835
G
TJP1
tight junction protein 1
affects localization
EXP
ochratoxin A affects the localization of TJP1 protein
CTD
PMID:14994279
NCBI chr 1:144,930,387...145,195,857
Ensembl chr 1:144,930,368...145,195,836
G
TLR4
toll like receptor 4
multiple interactions
EXP
ochratoxin A promotes the reaction [Lipopolysaccharides results in increased expression of TLR4 mRNA]; ochratoxin A promotes the reaction [Lipopolysaccharides results in increased expression of TLR4 protein]; TLR4 protein affects the reaction [ochratoxin A affects the expression of BCL2 mRNA]; TLR4 protein affects the reaction [ochratoxin A promotes the reaction [Lipopolysaccharides results in increased expression of IL1A mRNA]]; TLR4 protein affects the reaction [ochratoxin A promotes the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]]
CTD
PMID:28528741
NCBI chr 1:258,044,610...258,054,641
Ensembl chr 1:258,044,610...258,059,004
G
TNF
tumor necrosis factor
multiple interactions increases secretion
EXP
ochratoxin A promotes the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; TLR4 protein affects the reaction [ochratoxin A promotes the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]] ochratoxin A results in increased secretion of TNF protein
CTD
PMID:28528741 PMID:28699257
NCBI chr 7:23,699,635...23,702,393
Ensembl chr 7:23,699,636...23,703,655
G
TP53
tumor protein p53
multiple interactions increases expression
EXP
NFE2L2 protein affects the reaction [ochratoxin A results in increased expression of TP53 protein]
CTD
PMID:28710020 PMID:32454083
NCBI chr12:52,939,643...52,953,786
Ensembl chr12:52,939,643...52,953,819
G
XPA
XPA, DNA damage recognition and repair factor
decreases expression
EXP
ochratoxin A results in decreased expression of XPA mRNA
CTD
PMID:14994279
NCBI chr 1:239,532,331...239,568,589
Ensembl chr 1:239,532,246...239,568,649
G
XRCC1
X-ray repair cross complementing 1
increases expression
EXP
ochratoxin A results in increased expression of XRCC1 protein
CTD
PMID:32454083
NCBI chr 6:50,403,691...50,425,730
Ensembl chr 6:50,403,686...50,425,710
G
EIF2A
eukaryotic translation initiation factor 2A
increases phosphorylation
EXP
salubrinal results in increased phosphorylation of EIF2A protein
CTD
PMID:17464326
NCBI chr13:90,761,453...90,804,274
Ensembl chr13:90,761,465...90,804,276
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all